menu
    • menu

    Company profile for Kala Pharmaceuticals

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS® (lo...
    Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery Technology to two ocular therapies, EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of signs and symptoms of dry eye disease and INVELTYS® (loteprednol etabonate ophthalmic suspension) 1% for the treatment of post-operative inflammation and pain following ocular surgery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kala PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Beaver St., Suite 201 Waltham, MA 02453
    Telephone
    Telephone
    +1-781-996-5252
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kalarx.com:443/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kala-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    KALA BIO Settles Approximately $10.6 Million Of Debt
    KALA BIO Settles Approximately $10.6 Million Of Debt

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3213204/0/en/KALA-BIO-Settles-Approximately-10-6-million-of-Debt.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Kala Pharmaceuticals Announces Name Change to KALA BIO
    Kala Pharmaceuticals Announces Name Change to KALA BIO

    02 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/02/2716797/0/en/Kala-Pharmaceuticals-Announces-Name-Change-to-KALA-BIO.html

    GLOBENEWSWIRE
    02 Aug 2023
    Share Share
    Kala Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Kala Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    19 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/19/2707717/0/en/Kala-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    19 Jul 2023
    Share Share
    Kala Pharma Reports Inducement Grants Under Nasdaq Listing Rule
    Kala Pharma Reports Inducement Grants Under Nasdaq Listing Rule

    23 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/23/2693902/0/en/Kala-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    23 Jun 2023
    Share Share
    Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference
    Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference

    02 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/02/2681101/0/en/Kala-Pharmaceuticals-to-Present-at-the-Jefferies-Healthcare-Conference.html

    GLOBENEWSWIRE
    02 Jun 2023
    Share Share
    Kala Pharmaceuticals Reports1Q 2023 FYR and Provides Corporate Update
    Kala Pharmaceuticals Reports1Q 2023 FYR and Provides Corporate Update

    09 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/09/2664373/0/en/Kala-Pharmaceuticals-Reports-First-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    09 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search